María Guillamot

This study characterizes myeloid sarcoma through multi-omic profiling, identifies RAS pathway activation as a hallmark, and shows RAS inhibition reduces tumor burden in mouse models.

This study shows that transient skin inflammation activates hematopoietic stem/progenitor cells via type I interferon, altering systemic immunity and affecting atherosclerosis and influenza outcomes.